sequence identity in the complete capsid protein VP1 (5, 23) . However, for molecular epidemiological investigations, tentative genotyping methods based on partial genomic sequencing of the RNA-dependent RNA polymerase (RdRp) and capsid genes are commonly used (3, 10, 19, 20) . Between March and May 2004, an unusual increase in NoV-associated outbreaks was observed in Osaka City, Japan. In Osaka City, with a population of approximately 2.6 million, NoV surveillance is conducted by collecting a basic set of epidemiological data (age range of patients, setting of outbreak, mode of transmission, date of onset, and attack rate) and testing stool specimens. An outbreak of acute gastroenteritis is defined as two or more patients with diarrhea and or vomiting who are linked by place and time. Patients with acute gastroenteritis attending sentinel pediatric clinics in Osaka are included as sporadic cases (8) . Stool specimens were tested for NoV by reverse transcription-PCR (RT-PCR) using primers targeting the RdRp region until April 2001 (9) and by real-time RT-PCR since that time (18) . All GII.2 strains were characterized by both partial RdRp and capsid gene sequencing as follows. RT-PCR assays were developed to amplify long genomic fragments using different sets of primers: (i) primer pair LV4282-99F (5Ј-YCAY TATGATGCWGAYTA-3Ј)/N235Rex (5Ј-GCWANRAAAGCT CCWGCCAT-3Ј) for the partial RdRp and the complete capsid genes (2,451 bp) and (ii) LV4282-99F/G2SKR (12) for the partial RdRp and the capsid N-terminal/shell (N/S) genes (1,108 bp). The amplified fragments were sequenced in both orientations with the primers. Phylogenetic analysis and genotyping based on the capsid N/S domain were performed as described by Katayama et al. (11) . Assignment of genotype was based on the complete VP1 sequence according to Zheng et al. (23) and expressed as "genotype number-cap" (for example, "GII.2-cap"). Genotyping based on the RdRp region was performed using the criteria described by Vinjé et al. (19) . The RdRp genotype was expressed as "genotype number-pol" (for example, "GII.2-pol").
A total of 238 NoV-positive outbreaks and 300 positive sporadic cases were detected between April 1996 and March 2005. Most (91.6%) of the NoV-positive outbreaks occurred between November and March of each year, whereas 85.0% of the NoV-positive sporadic cases occurred between October and February of each year. Between March and May 2004, 11 GII.2-cap NoV-associated outbreaks were observed (Table 1) . In other years, a total of eight genetically different GII.2-cap strains, found on a separate branch on the phylogenetic tree (Fig. 1A) , were detected. Thus, the number of the GII.2-cap NoV-associated outbreaks in the spring of 2004 was unusual compared with those for other seasons and higher than in all previous years (Poisson distribution, P Ͻ 0.0001). No NoVassociated outbreaks were observed between June and October 2004.
Of the 11 GII.2-cap NoV-associated outbreaks in the spring of 2004, nine occurred in children (81.8%), whose most common transmission mode was person-to-person contact (63.6%) ( Table 1 ). In both children and adults, symptoms in GII.2-cap NoV-associated outbreaks were similar to those in outbreaks caused by other NoV genotypes. No epidemiological links were found among the outbreaks that could explain their spring emergence. In contrast, the eight genetically different GII.2-cap strains observed during our on October 15, 2017 by guest http://jcm.asm.org/ 9-year NoV surveillance were found mainly in December or January, mostly in adults, with transmission by the consumption of contaminated foods. Among sporadic cases, three GII.2-cap strains were detected in the spring of 2004. These cases seemed to be epidemiologically unrelated to the 11 outbreaks of the same period. From the genetic analysis, all GII.2-cap strains detected during the spring of 2004 (04spring strains) were classified into the GII.2 genotype at the RdRp region and were closely related to one another (Ն99.1% nucleotide and Ն98.5% nucleotide identities in RdRp and capsid N/S regions, respectively). The eight genetically distinct GII.2-cap strains from other seasons were segregated into GII.2 (strain 02012) and other four other genotypes (one GII.b and three GII-NA) at the RdRp region, suggesting that these four were recombinant strains (Fig. 1B) . Comparison of the amino acid sequences of the complete capsid genes revealed no common difference between the 04spring strains and the other GII2-cap strains (data not shown).
In this study, we focused on an unusual cluster of GII.2 NoV-associated outbreaks in spring 2004 in Osaka City. These GII.2-cap strains were rare in Osaka City in the previous 9 years of our surveillance. The spring 2004 outbreaks were distinct from the other GII.2-cap NoV-associated outbreaks in seasonality (spring versus winter), age of patients (children versus adults), and transmission mode (contact versus food). These occurrences could be explained by the rarity of GII.2 strains in the population. Since the strains were rare, children in Osaka City most likely did not have antibodies to the 04spring strains. The genetic characterization of these strains showed that they formed a distinct cluster that suddenly appeared, spread in Osaka City for a few months, and disappeared. Their disappearance may reflect acquisition of immunity to the 04spring strains in the population. Previous reports described the sudden emergence and disappearance of certain genotypes of NoV (6, 8, 9, 17) in a limited region. For GII.4 strains, this phenomenon has been observed globally (13, 15, 16, 22) . It is unclear why differences in behavior exist among NoVs belonging to different genotypes. The emergence of a GII.2 strain with matching RdRp and capsid genotypes as the dominant cause of a cluster of outbreaks suggests that recombination may affect the behavior of NoV strains. Most other GII.2 viruses found throughout the surveillance period were recombinant strains detected in isolated outbreaks. Gallimore et al. (4) likewise suggest that variants differ in their impact on public health according to the accumulation of point mutations and recombinants. Future studies using structured surveillance are needed to address this hypothesis and improve our understanding of NoV epidemiology. Such insight is essential to design evidence-based strategies for NoV control and prevention.
Nucleotide sequence accession numbers. The nucleotide sequences determined in this study were deposited in DDBJ with the following accession numbers: AB089882 and AB279553 to AB279576.
